Subjects: Buprenorphine -- supply & distribution - Digital Collections - National Library of Medicine Search Results

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

NLM Digital Collections

Start Over Subjects Buprenorphine -- supply & distribution

1. Geographic disparities affect access to buprenorphine services for opioid use disorder

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, January 2020
Subject(s):: Buprenorphine -- supply & distribution
Health Services Accessibility
Medically Underserved Area
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States
United States. Department of Health and Human Services
United States. Substance Abuse and Mental Health Services Administration

2. SAMHSA is missing opportunities to better monitor access to medication-assisted treatment through the buprenorphine waiver program

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, June 2021
Subject(s):: United States Substance Abuse and Mental Health Services Administration
Buprenorphine -- supply & distribution
Government Regulation
Opioid Epidemic
United States
United States. Department of Health and Human Services